Dofequidar (sesquifumarate), CAS [[158681-49-3]] Preis auf Anfrage

Produktübersicht

• Artikelname: Dofequidar (sesquifumarate), CAS [[158681-49-3]] Preis auf Anfrage
• Artikelnummer: MCE-HY-17013D
• Hersteller Artikelnummer: HY-17013D
• Alternativnummer: MCE-HY-17013D-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MS-209 (sesquifumarate)

Produktbeschreibung

Dofequidar (MS-209) sesquifumarate is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar sesquifumarate has highly potent reversing effect on multidrug-resistant tumor cells. Dofequidar sesquifumarate competitively inhibits ABCB1/P-gp, ABCC1/MRP-1, blocks the efflux of chemotherapeutic agents, increases the drug concentration in cancer cells, and enhances the chemotherapeutic effect[1][2].

Produkteigenschaften

• Molekulargewicht: 1311.39
• CAS Nummer: [158681-49-3]
• Formel: C30H31N3O3.3/2C4H4O4
• Target-Kategorie: P-glycoprotein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound